Haleon reported 2.6% organic sales growth for its third quarter: 2.1% from price and 0.5% from volume/mix. Revenue landed 2% below the FactSet consensus. Management lowered guidance for full-year organic sales growth to 2.5% from 4%. Shares were down 15% midday on Oct. 29.
We expect Haleon, with financial and operational independence, to bolster its portfolio through product innovation and tuck-in acquisitions and expand the strong foothold it has in the consumer self-care industry.
Personalization of health paves the way for smaller niche players to carve out their shares of the market with bespoke offerings, and Haleon will have a tough time fighting for these areas given the difficulty of catering to these consumers with their megabrands.
Metric | HLN | RKT | PG |
|---|---|---|---|
Price/Earnings (Normalized) | 18.87 | 20.81 | 24.44 |
Price/Book Value | 1.84 | 6.33 | 7.12 |
Price/Sales | 2.71 | 2.69 | 4.63 |
Price/Cash Flow | 13.99 | 15.13 | 21.02 |
Metric | HLN | RKT | PG |
|---|---|---|---|
Quick Ratio | 0.51 | 0.38 | 0.49 |
Current Ratio | 0.69 | 0.59 | 0.72 |
Interest Coverage | 7.45 | 8.84 | 23.11 |
Metric | HLN | RKT | PG |
|---|---|---|---|
Return on Assets (Normalized) | 5.49% | 9.05% | 12.95% |
Return on Equity (Normalized) | 10.94% | 33.99% | 30.92% |
Return on Invested Capital (Normalized) | 8.05% | 15.92% | 18.72% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|CNkZ&D# | LOCK|T>%<N | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|pLg$r&x# | LOCK|#^Tgg | $50B | |||
| Zoetis Inc Class A ZTS | LOCK|Lyd^m@L | LOCK|&^P | $34B | |||
| Viatris Inc VTRS | LOCK|dT&>$C@ | LOCK|>#p | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|@qK | LOCK|%@ | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|>h<S&hs | LOCK|x&k | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|Z&tQy@ | LOCK|^tL | $4B | |||
| Perrigo Co PLC PRGO | LOCK|##c<Tl | LOCK|tHH | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|xh@XYs? | LOCK|!@^&! | $2B |
United States